How Datavault AI Inc. is turning U.S. critical minerals into digital assets through American Strategic Minerals Inc. deal (NASDAQ: DVLT)
Spectral Medical (TSX: EDT) posts C$2.44m revenue as PMA submission slips to May 2026 and derivative liabilities widen the reported loss
Oxford Biomedica (LSE: OXB) delivers first EBITDA profit as revenue surges 33% and BMS CAR-T deal signals commercial maturity
Read More 5 minute read Healthcare Industry News Suraksha Diagnostic Q1 FY26 results: How revenue growth, genomics expansion, and acquisitions are shaping investor outlook Suraksha Diagnostic Q1 FY26 revenue up 18.83%, PAT up 19.67%. See how genomics, acquisitions, and expansion are shaping its growth outlook. byPallavi MadhirajuAugust 9, 2025